Evidence map›Paper›PMID 38720899›Full record

ArticleFrontiers in immunology2024

Collaboration between a cis-interacting natural killer cell receptor and membrane sphingolipid is critical for the phagocyte function.

Hitomi Karyu, Takahiro Niki, Yuriko Sorimachi, Shoji Hata, Shiho Shimabukuro-Demoto, Tetsuya Hirabayashi, Kojiro Mukai, Kohji Kasahara, Keiyo Takubo, Nobuhito Goda and 4 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Functions of Sulfatide in the Nervous, Immune, and Urinary Systems.Advances in experimental medicine and biology · 2026
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Hitomi KaryuDivision of Human Immunology, International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo (IMSUT), Tokyo, Japan.
Takahiro NikiLaboratory for Neural Cell Dynamics, RIKEN Center for Brain Science, Saitama, Japan.
Yuriko SorimachiDepartment of Life Science and Medical Bioscience, School of Advanced Science and Engineering, Waseda University, Tokyo, Japan.
Shoji HataTokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Shiho Shimabukuro-DemotoDivision of Human Immunology, International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo (IMSUT), Tokyo, Japan.
Tetsuya HirabayashiLaboratory of Biomembrane, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Kojiro MukaiDepartment of Integrative Life Sciences, Graduate School of Life Sciences, Tohoku University, Sendai, Japan.
Kohji KasaharaLaboratory of Biomembrane, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Keiyo TakuboDepartment of Stem Cell Biology, Research Institute, National Center for Global Health and Medicine, Shinjuku, Tokyo, Japan.
Nobuhito GodaDepartment of Life Science and Medical Bioscience, School of Advanced Science and Engineering, Waseda University, Tokyo, Japan.
Koichi HonkeDepartment of Biochemistry and Kochi System Glycobiology Center, Kochi University Medical School, Kochi, Japan.
Tomohiko TaguchiDepartment of Integrative Life Sciences, Graduate School of Life Sciences, Tohoku University, Sendai, Japan.
Hiroyuki SorimachiDepartment of Life Science and Medical Bioscience, School of Advanced Science and Engineering, Waseda University, Tokyo, Japan.
Noriko Toyama-SorimachiDivision of Human Immunology, International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo (IMSUT), Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inhibitory natural killer (NK) cell receptors recognize MHC class I (MHC-I) in

Indexed as

SphingolipidsAnimalsCell MembraneHumansKiller Cells, NaturalNK Cell Lectin-Like Receptor Subfamily APhagocytesPhagocytosisProtein BindingNK Cell Lectin-Like Receptor Subfamily ASphingolipids2 phagocytosiscis interactioninhibitory receptorlipid raftLy49macrophageMHC class Isphingolipids

Identifiers

PMID38720899
PMCPMC11076679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.